Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001310790 | SCV000530415 | likely benign | not provided | 2020-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000530369 | SCV000638565 | benign | Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311502 | SCV000847163 | likely benign | Inborn genetic diseases | 2016-06-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001310790 | SCV001500728 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | KIF1A: BP4, BP7 |
Genetic Services Laboratory, |
RCV001821197 | SCV002067169 | likely benign | not specified | 2018-06-20 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848786 | SCV002104849 | uncertain significance | Hereditary spastic paraplegia | 2021-05-18 | criteria provided, single submitter | clinical testing |